EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Form of Proxy for use at the 2022 First Extraordinary General Meeting to be held on Wednesday, December 21, 2022
PROPOSED CHANGE IN USE OF PROCEEDS FROM THE H SHARE OFFERING
Next Day Disclosure Return
Monthly Return of Equity Issuer on Movements in Securities
CLARIFICATION ANNOUNCEMENT
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSITS
INSIDE INFORMATION RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) FOR INHALATION APPROVED FOR EMERGENCY USE IN MOROCCO
DISCLOSEABLE TRANSACTION PURCHASE OF STRUCTURED DEPOSIT
Monthly Return of Equity Issuer on Movements in Securities
Next Day Disclosure Return
1
21
22
23
24
25
52
津公网安备12011602300399
